SCHEMBL5829699

SCHEMBL5829699

C1=Cc2c(c3cc4ccccc4cc3c3ccccc23)CC1

nearest known ligand 0.33

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ HIF1A Q16665 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ HPRT1 P00492 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22654590 0.93 ALDH1A1 (0.36) ALDH1A1CYP1A2LCKFYNADORA3
SCHEMBL31488668 0.85 — —
SCHEMBL3419708 0.85 — —
SCHEMBL8663158 0.80 — —
SCHEMBL31154592 0.79 ALDH1A1 (0.35) ALDH1A1MAPTACHE
SCHEMBL27575535 0.77 HPRT1 (0.41) ALDH1A1CYP1A2LCKFYNADORA3
SCHEMBL18435424 0.77 CYP2D6 (0.32) —
SCHEMBL19060732 0.76 HPRT1 (0.51) ALDH1A1CYP1A2LCKFYNADORA3
SCHEMBL22809230 0.76 CA1 (0.35) —
SCHEMBL9927322 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0333554-B1 THERMAL-TREATMENT PROCESS OF HYDROCARBON FEEDS IN THE PRESENCE OF POLYSULFIDES AND HYDROGEN DONORS Institut Français du Pétrole (FR) 1992-09-02 — — EP claimed
EP-0333554-A1 Thermal-treatment process of hydrocarbon feeds in the presence of polysulfides and hydrogen donors Institut Français du Pétrole (FR) 1989-09-20 — — EP claimed
US-7119206-B2 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators ELI LILLY AND COMPANY (US) 2006-10-10 — — US disclosed
US-20060122386-A1 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators ELI LILLY AND COMPANY 2006-06-08 — — US disclosed
CN-1684958-A Dihydro-dibenzo (A) anthracenes and relative compounds,composition and method LILLY CO ELI (US) 2005-10-19 — — CN disclosed
EP-1546139-A1 DERIVATIVE OF DIHYDRO-DIBENZO (A) ANTHRACENES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-29 — — EP disclosed
WO-2004029047-A1 DERIVATIVE OF DIHYDRO-DIBENZO (A) ANTHRACENES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-04-08 — — WO disclosed
EP-0333554-B1 THERMAL-TREATMENT PROCESS OF HYDROCARBON FEEDS IN THE PRESENCE OF POLYSULFIDES AND HYDROGEN DONORS Institut Français du Pétrole (FR) 1992-09-02 — — EP disclosed
EP-0333554-A1 Thermal-treatment process of hydrocarbon feeds in the presence of polysulfides and hydrogen donors Institut Français du Pétrole (FR) 1989-09-20 — — EP disclosed
EP-0063052-B1 STARTING PITCHES FOR CARBON FIBERS NIPPON OIL CO. LTD. (JP) 1986-09-03 — — EP disclosed
EP-0063053-B1 STARTING PITCHES FOR CARBON FIBERS NIPPON OIL CO. LTD. (JP) 1986-03-12 — — EP disclosed
US-4521294-A Starting pitches for carbon fibers NIPPON OIL CO., LTD. (JP) 1985-06-04 — — US disclosed
US-4397830-A HEAT TREATMENT OF HEAVY OIL AND HYDROGENATED HEAVY OIL NIPPON OIL CO., LTD. (JP) 1983-08-09 — — US disclosed
EP-0063052-A2 Starting pitches for carbon fibers NIPPON OIL CO. LTD. (JP) 1982-10-20 — — EP disclosed
EP-0063053-A2 Starting pitches for carbon fibers NIPPON OIL CO. LTD. (JP) 1982-10-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122386-A1 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators ESR1, GPER1, ESR2 ALDH1A1 1604/4885CYP1A2 503/4885LCK 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback